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Feel like you need a little Viagra but you're too embarrassed to
talk to your doctor? Want to combat that baldness with some
Minoxidil but you just don't have time to see your personal
physician? Perhaps you want to shed a few pounds with the help of
one of those prescription diet drugs? No problem-if you have access
to the Internet and a credit card.' Today, healthcare consumers can
go online and purchase virtually any type of prescription medication,
with or without a valid prescription from their physician.2
An Internet pharmacy sells medications through its Web site.
3
Some of these pharmacies are simply the cyberspace version of
traditional brick-and-mortar pharmacies.4  Other pharmacies only
exist in the cyberworld and prescriptions are filled and shipped from a
warehouse.5 Legitimate, law-abiding Internet pharmacies benefit
modern healthcare in numerous ways.6  However, some Internet
pharmacies conduct illegal and unsafe prescribing and dispensing
practices that can endanger the health of the patients that the
pharmacies serve.7
* J.D. candidate, Chicago-Kent College of Law, Illinois Institute of Technology, 2002;
B.S., D.P.M., Dr. William M. Scholl College of Podiatric Medicine, 1997; B.A., Creighton
University, 1993. The author wishes to thank Professor Ed Kraus, Susan E. Cowell, and John
Rost for their helpful comments during the writing and editing of this Note. A previous version
of this Note won third place in the 2000 H. Thomas Austern Memorial Writing Award
Competition sponsored by the Food and Drug Law Institute ("FDLI"), and was published in 55
FOOD & DRUG L.J. 619 (2000). This Note is being reprinted with permission of the FDLI.
1. See generally Carol Ukens, Internet Pharmacies, DRUG TOPICS, May 17, 1999, at 63,
available at LEXIS, News Library, DRUGTP File.
2. See id.
3. See id.; see also Keith M. Korenchuk, Online Pharmacies Present a Host of Regulatory
Issues, NAT'L L.J., Nov. 29, 1999, at Bl, available at LEXIS, News Library, NTLAWJ File.
4. See id.
5. See Angela Gunn, Behind the Scenes at an Online Pharmacy, at <http://www.cnn.com/
tech/computing/9910/05/web.pharmacy.idg/index.html> (Oct. 5, 1999).
6. See infra Part I.B.
7. See infra Part I.C.
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Essentially, three types of Internet pharmacies exist:8 (1)
pharmacies that only fill prescriptions written by a patient's physician;
(2) pharmacies that charge the patient for a physician "cyber-
consultation" 9 (which usually consists of nothing more than a simple
questionnaire) and then write a prescription for the patient;10 and (3)
pharmacies that dispense prescription drugs without a physician's
prescription." The first type of pharmacy is a valuable addition to the
healthcare consumer industry and is considered to be the cyberspace
equivalent of a mail-order pharmacy. 12 The latter two types of
pharmacies, however, can present a significant danger to healthcare
consumers and are proving to be a regulatory nightmare.
The number of Internet pharmacies has increased from less than
thirty in January of 1999 to more than 400 in July of 1999.13
Furthermore, a July, 1999 report issued by the American Medical
Association's ("AMA") Board of Trustees estimated that at least 400
"instant prescription" Web sites exist.14 Typically, instant prescription
sites require that the consumer accept the terms of a liability waiver,
select a quantity of the drug to be purchased, and complete a brief
online questionnaire.1" The pharmacies claim that completed ques-
tionnaires are evaluated by a physician, who prescribes the medi-
cation if it is medically indicated.
16
A special regulatory problem arises when the Internet pharmacy
is located outside the United States. Foreign sites fall outside the
regulatory jurisdiction of the United States.
7 The Customs Service ,18
8. See Michael F. Conlan, Net Watchers: Congress Weighs New Laws As It Probes the
Practices of Online Pharmacies, DRUG ToPics, Aug. 16, 1999, at 71, available at LEXIS, News
Library, DRUGTP File.
9. See Ukens, supra note 1, at 63.
10. See id. At one pharmacy, affiliates received a ten dollar referral fee for every new
Viagra sale, plus 2.5% of the product price. Affiliates could also earn an extra $400 to $8,000
each month, with top prescribers earning $15,000 per month. Id.
11. See id.
12. See id.
13. See William Glanz, FDA Warns Against Cyber-Drugs; Agency Vows to More Closely
Scrutinize Online Pharmacies, WASH. TIMES, July 31, 1999, at C7.
14. See Douglas Carnall, American Medical Association Moves to Regulate Prescribing on
the Internet, 319 BRIT. MED. J. 213,213 (1999).
15. See id.
16. See Ukens, supra note 1, at 63. One company pays two independent physicians on a
percentage basis to assess its questionnaire forms. See Carnall, supra note 14, at 213. The
company's managing director stated, "Our business is to sell lifestyle treatments to people who
have proven their intelligence by accessing the internet and owning a credit card." Id.
17. See Marilynn Larkin, US Online Pharmacies Strive for Respectability, 354 LANCET 782,
782 (1999).
18. Even though it is illegal to ship undeclared drugs into the United States, it is impossible
for the United States Customs Service to screen all incoming packages. See Katrina Armstrong
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the Postal Service, the Food and Drug Administration ("FDA"), and
the Drug Enforcement Administration ("DEA") all play important
roles in taking action against the illegal importation of drugs.' 9
Controversy exists over which regulatory body should govern the
sale of prescription drugs over the Internet and how Internet
pharmacies should be regulated.20  This Note contends that
cooperation of state and federal regulatory agencies and careful
updating and utilization of current regulatory avenues can adequately
promote the safety of Internet pharmacies. This Note further
contends that dangers posed by the foreign Internet pharmacies will
grow until international regulatory cooperation is established.
Part I of this Note begins with background information and
statistics regarding the healthcare consumer's use of the Internet.
This Part outlines both the beneficial and detrimental effects of
Internet pharmacies and discusses privacy issues encountered upon
utilization of Internet pharmacies. Part II discusses the related issue
of regulation of the practice of cybermedicine. Part III explores the
regulatory issues and problems encountered in governing Internet
pharmacies and their prescribing and dispensing practices. This
discussion includes the regulatory stance of several agencies and
associations. Part III concludes with current statutory information,
case law, and pending legislative action. Part IV discusses the
opposing views of the critics and supporters of federal legislation, and
proposes model state legislation designed to promote the safety of
online prescription purchasing. Finally, Part IV discusses avenues for
dealing with foreign Internet pharmacies.
et al., Direct Sale of Sildenafil (Viagra) to Consumers over the Internet, 18 NEw ENGLAND J.
MED. 1389, 1391 (1999).
19. See Drugstores on the Net: The Benefits and Risks of Online Pharmacies Before the
Subcomm. on Oversight and Investigations Comm. on Commerce, 106th Cong. 93 (1999)
(statement of Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research, U.S.
Food & Drug Administration) [hereinafter Woodcock statement].
20. See Valentine Cardinale, In Step with Online Pharmacies, DRUG TOPICS, Aug. 2, 1999,
at 10, available at LEXIS, News Library, DRUGTP File; see also Larkin, supra note 17, at 782;
Craig L. Fuller, No Need to Expand Rules Yet, USA TODAY, Jan. 3, 2000, at 18A ("Rushing to
expand the authority of the FDA to regulate Internet pharmacies prior to any indication that
current regulatory and voluntary certification programs have failed may be a bit premature.").
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I. THE ADDITION OF INTERNET PHARMACIES TO THE INTERNET
CONSUMER HEALTHCARE ARENA
Consumers frequently utilize the Internet to obtain health
information and products,2' and Internet pharmacies join a wide
variety of healthcare Web sites. These pharmacies can be greatly
advantageous to the modern healthcare system. However, the un-
lawful practices of some pharmacies can detrimentally affect a con-
sumer's health.
A. The Healthcare Consumer's Use of the Internet and the
Economics of Prescription Purchasing
It is estimated that 48 million people accessed the Internet in
1998 and that number is expected to increase to at least 320 million by
2005.22 Furthermore, twenty percent of people on the Internet are
aged fifty or older and this age group represents the fastest growing
segment of the Internet community. 23 More than one-third to almost
one-half of these people seek medical and health information online.
24
Thus, it seems that an increasing number of people utilize the
Internet as a health resource.
An upward trend is also expected in prescription writing. In
1998, United States doctors wrote 2.8 billion prescriptions; this
number is expected to rise to 4 billion by 2005.2 The increase in
prescription purchases will foster an already profitable pharmacy
21. See infra Part I.A.
22. See Michael Casey, The Internet Writes Its Own Prescription, MED. INDUS. TODAY,
Mar. 24, 1999, available at LEXIS, News Library, MEDTDY File.
23. See Rita Rubin, Easier-to-Swallow Way to Get Your Pills Refilled, E-Pharmacies Offer
Convenience but Raise Safety Concerns, USA TODAY, Oct. 6, 1999, at 1D.
24. See Casey, supra note 22; see also Online Service Growing Rapidly; Net Pharmacy Signs
Medicare, MED. INDUS. TODAY, Apr. 8, 1999, available at LEXIS, News Library, MEDTDY
File.
25. See Michael Menduno, Apothecary Now; Online Pharmacies, HOSPS. & HEALTH
NETWORKS, July 1, 1999, at 34, available at LEXIS, News Library, HOSPTL File; see also
Casey, supra note 22. Approximately seventy-five percent of all prescriptions are written for
consumers with chronic conditions, and many of these consumers are interested in buying their
prescriptions online. See Kim Roller, Pharmacy and the Internet.- Danger or Opportunity?,
DRUG STORE NEWS, Aug. 30, 1999, at CP6, available at LEXIS, News Library, DRGSTR File.
The largest consumers of prescription drugs are over the age of fifty-five. See Reuters Health
Information, Online Drugstore Growth Predicted (Aug. 26, 1999) [hereinafter Reuters] (on file
with author). However, as discussed supra, this age group still represents a small percentage of
Internet users. See Rubin, supra note 23, at 1D. It is predicted that the aging, "technology
savvy" baby boomers will fuel future growth of Internet pharmacies. See Reuters, supra.
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business.2 6 The lucrative pharmaceutical industry could make online
drugstores "one of the hottest categories in e-commerce.
''2 7
B. Positive Effects of Internet Pharmacies
Internet pharmacies offer a host of benefits. They are
convenient and allow customers to avoid nuisances such as going out
in bad weather, parking hassles, standing in line, and the inevitable
wait for the prescription to be filled.2 8 Patients with limited mobility
or those living far from a pharmacy can benefit tremendously from
legitimate Internet pharmacies by eliminating travel to a traditional
pharmacy.2 9 Many Internet pharmacies offer overnight shipping,
allowing customers to avoid the delay of regular mail.3 0
Another benefit is that some Internet pharmacies offer lower
prices on medications than those charged by traditional pharmacies.31
An increase in competition is one way to make lower costs possible.
32
In addition, many Internet pharmacies lack fixed costs such as
property leases, maintenance, and property taxes. 3
Furthermore, Internet pharmacies can offer privacy that is often
lacking in a traditional pharmacy.3 4 Many patients feel uncomfortable
asking a pharmacist questions in front of other customers.35  Some
Internet pharmacies have a licensed pharmacist available twenty-four
26. United States consumers spend approximately $230 billion per year for prescription
drugs and other healthcare items. See Casey, supra note 22. The mail-order drug business
makes approximately $15 billion annually. See Reuters, supra note 25. Estimates predict an
increase in online drug sales, from $11 million in 1998 to $890 million in 2002, provided more
insurance companies agree to pay for prescription medication ordered and dispensed this way.
Id.
27. See James Ledbetter, No Prescription? No Problem: Online Drugstores Don't Always
Work the Way You'd Expect, at <http://wwwl.pcworld.com/pcwtoday/article/0,1510,116-
33,00.html> (June 30, 1999). But see The Economist, Online Pharmacies Suffering Some Profit
Queasiness, CHI. TRIB., Dec. 20, 1999, at 4 (discussing the minimal revenues and large losses of
certain Internet pharmacies).
28. See Rubin, supra note 23.
29. See Woodcock statement, supra note 19.
30. See Ukens, supra note 1, at 63.
31. See John Henkel, Buying Drugs Online: It's Convenient and Private, but Beware of
"Rogue Sites", FDA CONSUMER, Jan.-Feb. 2000, available at LEXIS, News Library, FDA File;
see also Rubin, supra note 23.
32. See Woodcock statement, supra note 19.
33. See Casey, supra note 22.
34. See generally Ukens, supra note 1, at 63. However, there is some question as to the
degree of anonymity the Internet provides. For a discussion of the "trail of data" left behind
while surfing the Web, see Jerry Berman & Dierdre Mulligan, The Internet and the Law: Privacy
in the Digital Age: Work in Progress, 23 NOVA L. REV. 549, 558-59 (1999).
35. See generally Ukens, supra note 1, at 63; see also Rubin, supra note 23.
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hours a day to answer questions by phone or by e-mail.36 This allows
patients to ask personal medication questions without fearing that
their neighbor might overhear.
A final benefit is that Internet pharmacies can offer perks not
found in traditional pharmacies. Some companies send e-mail alerts
when the prescription is due for a refill;37  such a reminder may
improve patient compliance with drug therapies. Improving therapy
compliance is not only beneficial to the patient's physical health, but
it is also possible that the cost of healthcare paid by insurers,
employers, and third-party payers could be reduced by improving
patient outcomes.38
C. Negative Effects of Internet Pharmacies
Although Internet pharmacies can provide many benefits, the
unlawful activities of many of these sites produce deleterious effects.
Distinguishing legitimate Internet pharmacies from illegitimate
pharmacies is difficult because of the ease of creating a Web site that
looks like it represents a valid company.39 Furthermore, obscuring
the source of the medication and the companies responsible for
producing and dispensing it is simple with Internet technology.40
Two dangers that go hand in hand are self-diagnosis and self-
medication because consumers can purchase prescription drugs
without ever speaking to a pharmacist or physician.41 In these days of
managed care, it might be weeks before a patient can see a physician
for nonemergency purposes.42  Patients might choose to treat
themselves rather than wait for an appointment, or the patient may
36. See Gunn, supra note 5.
37. See Casey, supra note 22.
38. See id.
39. See Woodcock statement, supra note 19; see also White House Press Release, The
Clinton Administration Unveils New Initiative to Protect Consumers Buying Prescription Drug
Products over the Internet, Dec. 28, 1999 [hereinafter White House Press Release]. But see
Fuller, supra note 20, at 18A ("[I]t is an overstatement by the White House to suggest that
consumers have 'no way of telling' whether an online pharmacy is a legitimate operation."); see
also Virginia Postrel, Sometimes the Patient Knows Best, N.Y. TIMES, Jan. 3, 2000, at A19
("Brand reputations, contact numbers and street addresses, and a pharmacy association
certification program are all indicators that a business is sound.").
40. See Woodcock statement, supra note 19.
41. See White House Press Release, supra note 39. But see Postrel, supra note 39
("Regulators also tend to idealize in-person exams, as though every doctor took a careful
history and thoroughly examined a patient before prescribing any drug.").
42. See Ledbetter, supra note 27.
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simply be too embarrassed to discuss the health problem with his
physician. 3
These dangers are especially significant when Internet phar-
macies are willing to dispense prescription drugs without a valid
prescription." When a patient utilizes an Internet pharmacy that
provides a medication based on a cyber-consultation, or if the
pharmacy directly dispenses the medication without a prescription,
important safeguards are missed a.4  Not only does the patient miss an
examination by his physician, but the possibility exists that a licensed
pharmacist may never review the prescription.46 The patient bypasses
the two professionals who traditionally inform patients of proper
utilization, dangerous side effects,47 and drug interactions.
4 8
In addition to the safety issues raised by illegitimate dispensation
of medication, the prescription label itself can pose potential dangers.
Medicines obtained through rogue Internet pharmacies might contain
unreliable or out-of-date prescription use and dosage instructions.4 9
The instructions might even be printed in a foreign language. 0
43. One Internet pharmacy, PrescriptionRx.com <http://www.prescriptionrx.com>, an
information source on foreign pharmacies, offers a listing of more than one thousand
pharmacies worldwide that provide medications without a prescription. See Ukens, supra note
1, at 63. PrescriptionRx.com also sells the "Self-Diagnostic Symptom Cross Reference," a CD-
ROM that provides a list of possible ailments and suggests medications after users type in their
symptoms. Id. Thus, healthcare consumers can diagnose their medical problem and
subsequently order medication without ever seeing or talking to a doctor.
44. See supra note 14 and accompanying text.
45. See Armstrong et al., supra note 18, at 1389; see also White House Press Release, supra
note 39. One instance of where these important safeguards were missed was when a fifty-two-
year-old Illinois man with a history of chest pain and a family history of heart disease died of a
heart attack after using Viagra, which he had purchased via the Internet after completing an
online questionnaire. See Henkel, supra note 31. Officials believe that a traditional doctor-
patient relationship and physical examination could have uncovered health problems such as
heart disease, which is a contraindication to using Viagra. Id. Another example emphasizing
the necessity of a face-to-face physician consultation is where a person suffering from anorexia
nervosa or another eating disorder attempts to receive a diet drug prescription. See National
Association of Boards of Pharmacy: Executive Officers Conference (Sept. 28, 1999) (prepared
statement of Jane E. Henney, M.D., Commissioner of Food and Drugs, U.S. Food & Drug
Administration). A physician prescribing the medication on the basis of an online consultation
would be unable to determine the inappropriateness of the prescription. Id.
46. See Armstrong et al., supra note 18, at 1389; see also White House Press Release, supra
note 39.
47. See Steven N. Gange, M.D., Viagra: The Risks of Getting It off the Internet, at
<http://www.cnn.com/health/men/9910/01/viagra.men.wmd/> (Oct. 1, 1999).
48. See Armstrong et al., supra note 18, at 1389.
49. See World Health Organization, Medical Products and the Internet: A Guide to Finding
Reliable Information, at <http://www.who.int/medicines/docs/Medicines-on-Internet-Guide.
html> (last visited Feb. 1, 2000) [hereinafter WHO Guide].
50. See id.
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Another drawback to Internet pharmacies may be cost, as some
consumers pay more for prescription medications obtained over the
Internet. 51 High shipping costs and an inability to participate in many
insurance plans add to the cost.52 Furthermore, it is unlikely that
health insurance plans cover the cost of an online medical
consultation.53 Online consultations with a physician typically cost
more than a visit to the patient's own primary care physician.5 4 The
cost escalates if the patient has to pay for additional cyber-
consultations for prescription refills. 55 In comparison, if the patient's
personal physician writes the prescription, it is more likely that the
prescription could be refilled without the cost of an additional office
visit.
Another area of concern involves the prescribing physician's
credentials. The cyber-doctor's qualifications and his experience may
be questionable, yet the patient has no way to screen the physician. 6
The possibility exists that the prescribing physician is practicing out of
his area of specialty; in the non-cyberworld, patients would not
typically visit an orthopedist to obtain a prescription for Viagra.57
Furthermore, the online medical consult questionnaires utilized
by many Internet pharmacies pose several dangers. The AMA voiced
concern that terms used in the online questionnaires may be beyond
51. A study of forty-six Internet pharmacies that sell prescription medications directly to
the public indicated that drug prices were actually higher than those found in a traditional
pharmacy. See Bernard S. Bloom & Ronald C. lannacone, Internet Availability of Prescription
Pharmaceuticals to the Public, 131 ANN. INTERNAL MED. 830, 830 (1999). For example, the
price for Viagra from the Internet pharmacy was approximately $5.49, plus the cost of shipping,
whereas the price was $4.50 per pill from a local Philadelphia pharmacy. Id. Thirty-seven of the
sites required a prescription from a personal physician or an online physician; however, nine
sites located outside the United States required neither a prescription nor an online consultation
with a physician. Id.
52. See Ukens, supra note 1, at 63. Some Internet pharmacies can contract with pre-
scription insurance plans, however, many other pharmacies do not participate with insurance
plans, and the consumer must pay for the medications out-of-pocket. See WHO Guide, supra
note 49. Health Maintenance Organizations ("HMOs") and insurance companies pay for more
than eighty percent of all prescription drug costs. See Casey, supra note 22.
53. See Kiplinger's Magazine, The Pain of Online Drugstores, Aug. 28, 1999 (on file with
author).
54. See Bloom & Iannacone, supra note 51, at 832; see also Reuters Health Information,
Internet Pharmacy Sites Under Fire, Sept. 30, 1999 (on file with author).
55. See Bloom & lannacone, supra note 51, at 831. For example, of the United States-
based Internet pharmacies in one study, prescriptions could only be refilled twice, after which
another online consultation was required. Id.
56. One Internet pharmacy claims to have a "board-certified" physician, but does not give
the physician's name, location, or even the board certification area of specialty. See ePrescribe,
at <http://www.eprescribe.com> (last visited Feb. 1, 2000).
57. See generally Sheryl Gay Stolberg, Virtual Druggists: A Special Report, lnternet
Prescriptions Boom in the "Wild West" of the Web, N.Y. TIMES, June 27, 1999, at 1.
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the technical comprehension of the lay person, and that there is no
mechanism to ensure that the questions have been answered correctly
or to confirm the proffered history with a physical examination.18
Moreover, patients may underestimate the importance of the
questions being asked. 59 Finally, many online questionnaires have the
answers preselected for the patient.60 This is hazardous because it
facilitates the patient providing false or incorrect information.
61
An additional danger is consumer access to unapproved drugs,62
counterfeit medications, and products marketed with fraudulent
health claims.63 Patients suffering from a serious medical problem
and desperately searching for a cure are particularly vulnerable to
false claims and unapproved drugs.64 Furthermore, rogue sites might
not send the real medication. 65  Patients might actually receive
counterfeit drugs that contain inactive ingredients, expired legitimate
medications diverted to illegitimate sellers, or "dangerous sub-potent
or super-potent versions that were improperly manufactured." 66
Finally, if drugs are manufactured, packaged, transported, or stored
under substandard conditions, the drugs could contain impure or
unknown ingredients.
67
D. Privacy Issues Encountered with Internet Pharmacies
Although there is no guarantee of privacy at a traditional
pharmacy, the information transmitted and stored by Internet
pharmacies is vulnerable to hackers.68 Much of the vulnerability can
58. See Carnall, supra note 14, at 213. AM. MED. ASS'N, REPORT OF THE BOARD OF
TRUSTEES, 35-A-99, at 1, available at <http://www.ama-assn.org/meetings/public/annua99/
reports/onsitelbot/rtf/bot35.rtf> (last visited Mar. 28, 2000) [hereinafter AMA BOT REPORT].
59. See Armstrong et al., supra note 18, at 1390.
60. See Bloom & lannacone, supra note 51, at 833.
61. See id.
62. Internet pharmacies based outside the United States enable patients to obtain
medications that have not been approved by the FDA. See Drugstores on the Net: The Benefits
and Risks of Online Pharmacies Before the Subcomm. on Oversight and Investigations Comm.
on Commerce, 106th Cong. 251 (1999) (statement of Herman I. Abromowitz, M.D., American
Medical Association) [hereinafter Abromowitz statement]. Although the FDA requires
rigorous clinical trials prior to approving medications in the United States, drugs from outside
the United States typically escape such testing. Id.
63. See id.
64. See id.
65. When a Web site offers medications at a cost significantly lower than average, the pills
might not contain the active drug. See Armstrong et al., supra note 18, at 1391.
66. See Woodcock statement, supra note 19.
67. See id.; see also WHO Guide, supra note 49.
68. See generally Berman & Mulligan, supra note 34, at 566.
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be overcome if the pharmacy uses secure server technology,
maintains strict policies against sharing or selling patient personal
data, and encrypts transactions during transmission. 69 However, not
all Internet pharmacies make such a commitment to privacy.
70
Furthermore, certain practices of both Internet pharmacies and
traditional pharmacies raise privacy concerns. 71 Some drugstores sell
confidential patient information to third parties conducting marketing
campaigns for drug manufacturers. 72 This inappropriate or inad-
vertent disclosure of private medical or prescription information can
lead to a variety of problems, such as employment discrimination,
increased health or life insurance premiums, and even denial of
insurance coverage. 73
II. RELATED ISSUE: CURRENT REGULATION OF CYBER-MEDICINE
The current physician licensing system is state-based. 74  Some
critics argue that the state-based physician licensing system should be
abolished because of the common nature of providing health care.
75
Physicians can be licensed by more than one state; however, the
process is often both difficult and time-consuming because physicians
69. See id. One Internet pharmacy, Drugstore.corn (last visited Feb. 1, 2000) <http://
www.drug-store.com>, reportedly has policies against selling information to third parties, stores
health information and personal information in different places than patients' names, and
encrypts information before it is sent over the Internet. See Confidentiality and the Virtual
Pharmacy; Confidentiality of Prescription Information Given to Online Pharmacies, BuS. &
HEALTH, Apr. 1, 1999, at 7, available at LEXIS, News Library, BHLTH File [hereinafter
Confidentiality and the Virtual Pharmacy].
70. See WHO Guide, supra note 49.
71. See generally Rubin, supra note 23, at 1D. Some drug manufacturers and pharmacies
combine technology, marketing techniques, and patient prescription information to increase
medication sales. Id. One technique currently used by drug advertisers and manufacturers
involves gathering and storing personal information about people calling toll-free numbers for
information on medications. Id.
72. See Confidentiality and the Virtual Pharmacy, supra note 69, at 7. The United States
Department of Health and Human Services recently published proposed standards for privacy
protection of electronic health information. See 64 Fed. Reg. 59918 (Nov. 3, 1999). Further-
more, some states are trying to combat this trend of releasing prescription information. For
example, Virginia legislators are working on legislation to expand prohibitions against the
release of confidential prescription information by pharmacists, pharmacy owners, insurers, and
others with access to the data. See Robert O'Harrow, Jr., Giant Food Stops Sharing Customer
Data; Prescription-Marketing Plan Drew Complaints, WASH. POST, Feb. 18, 1998, at A01.
73. See Cheryl Clark, Medical Privacy Is Eroding, Physicians and Patients Declare, SAN
DIEGO UNION-TRIB., Feb. 21. 1998, at 1.
74. See generally Brian Darer, Telemedicine: A State-Based Answer to Health Care in
America, 3 VA. J.L. & TECH. 4 (1998).
75. See id at 13 n.36.
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must take additional exams, submit paperwork for credentialing, and
pay fees.
76
Because the licensing system is state-based, state regulatory
boards and agencies can reprimand 77 physicians who sell or prescribe
medications to patients the physician has not physically examined.
78
In light of these newly-encountered problems, the practice of
medicine will likely face regulatory adaptations designed to counter
any deleterious effects arising from technological advances. The
regulation of cyber-medicine is a necessary parallel to successful
regulation of Internet pharmacies.
79
III. REGULATORY ISSUES AND PROBLEMS ENCOUNTERED IN
GOVERNING INTERNET PHARMACIES
The general regulatory problem is two-fold: How should Internet
pharmacies be regulated and who has the authority to do so? Several
agencies claim that the problems presented by rogue pharmacies do
not fall within their jurisdictional authority; 0 thus, the issue has
become something of a regulatory hot potato. Furthermore, Internet
pharmacies raise a choice-of-law problem. 81 Such a situation arises
where an Internet pharmacy licensed in California contracts with a
physician licensed in New York to write a prescription for an online
patient in Michigan. Controversy exists over which state law should
apply in these multistate situations.
82
Rogue pharmacies present two additional regulatory problems:
(1) the ease of creating and operating an Internet Web site allows
76. See id at 17.
77. Reprimands vary in their degree of severity. For example, in October 1999, the
Colorado State Board of Medical Examiners sent a letter of admonition to a Colorado physician
for selling Viagra online. See Russ Colchamiro, Internet Rxs Cause Safety, Ethics Uproar, AM.
DRUGGIST, Jan. 1, 1999, at 14. In another instance, California state regulators shut down two
Web sites (<http://www.drpropecia.com> and <http://www.deyarmanmedical.com>) run by a
San Diego osteopath who was prescribing Propecia for baldness treatments without first
examining the patient. See Ledbetter, supra note 27. Finally, a state of Washington orthopedic
surgeon was fined $500 and cited by the Washington Medical Quality Assurance Commission
for unprofessional conduct for prescribing medication to people he had not physically
examined. See Stolberg, supra note 57, at 1.
78. For a further sampling of state medical board reprimands stemming from Internet
prescribing, see VA. BD. OF MED., DEPARTMENT OF HEALTH PROFESSIONS STUDY REPORT,
STUDY OF THE SALE OF PRESCRIPTION DRUGS VIA THE INTERNET 8-11, available at
<http://www.dhp.state.va.us/BHP/internet-prescribing-study-report.htm> (last visited Mar. 28,
2000) [hereinafter VIRGINIA STUDY REPORT].
79. See infra Parts III and IV.
80. See Ukens, supra note 1, at 63.
81. See id.
82. See VIRGINIA STUDY REPORT, supra note 78, at 2.
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these companies to close down their current site and open up a new
site within a matter of hours,83 thus making the pharmacies difficult to
track; and (2) many of these pharmacies are foreign companies and
out of the reach of the regulatory arm of the United States.84
A. An Overview of the Regulatory Stance of Interested Agencies and
Associations
Various federal and state authorities occupy specific, parallel
roles in the regulation of physicians and pharmacies. In an effort to
coordinate these separate entities, an interagency working group,
comprised of federal and state representatives, began meeting in
April of 1999 to discuss regulation of Internet pharmacies and
consider other issues relating to the sale of drugs over the Internet.85
1. The Regulatory Stance of the Food and Drug Administration
Regarding Internet Pharmacies
Under the Food, Drug, and Cosmetic Act the FDA has the legal
authority to take action against: (1) the importation, sale, or
distribution of an adulterated or misbranded drug; (2) the impor-
tation, sale, or distribution of an unapproved new drug; (3) illegal
promotion of a drug; (4) the sale or dispensing of a prescription drug
without a valid prescription; and (5) counterfeit drugs.86 FDA
officials believe that because the drug industry's products are being
sold, those companies should play a more active role in monitoring
Internet pharmacies. 87 The FDA further believes that issues raised by
Internet pharmacies should be handled by state regulatory boards
and other appropriate agencies.
88
83. See Ukens, supra note 1, at 63.
84. See Larkin, supra note 17, at 782.
85. See Drugstores on the Net: The Benefits and Risks of Online Pharmacies Before the
Subcomm. on Oversight and Investigations Comm. on Commerce, 106th Cong. 44 (1999)
(statement of Jodie Bernstein, Director of the Bureau of Consumer Protection of the FTC)
[hereinafter Bernstein statement]. The working group is comprised of representatives from of
the FTC, FDA, DOJ, DEA, and other federal and state agencies. Id.
86. See Woodcock statement, supra note 19; see also Federal Food, Drug, and Cosmetic
Act, 21 U.S.C. § 301 (2000).
87. See Colchamiro, supra note 77, at 14. At least one drug manufacturer declared its
stance against rogue pharmacy practices. Pfizer, the manufacturer of Viagra, reports to have
written letters to every state medical and pharmacy board to enlist their support in discouraging
the practice of online prescribing. Id. Pfizer has also filed a complaint with the FTC asking it to
monitor improper dispensation of Viagra. See Gange, supra note 47.
88. See Carol Ukens, NABP Maps Plans to Verify Internet Pharmacy Licenses, DRUG
TopIcs, Mar. 1, 1999, at 17.
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The FDA purports to lack both the resources and staff needed to
deal with the issues raised by Internet pharmacies and online
prescribing. 89 However, the FDA's Office of Regulatory Affairs and
Office of Compliance in the Center for Drug Evaluation and
Research are reviewing drug sales of Internet pharmacies that are
reported to appear violative of current federal law. 90 The FDA plans
to install a search engine9l to help its staff quickly find sites selling
prescriptions.92 Additionally, the FDA has sent warning letters to
companies illegally selling unapproved new drugs online and has
contacted online sellers of illegal foreign pharmaceuticals. 93 The
FDA considers foreign Internet pharmacies to be the most chal-
lenging problem.
94
The FDA also contacts Web site managers and asks for their
voluntary cooperation in removing violative sites.95 The FDA further
targets sites making unsubstantiated claims or misrepresentations of
drugs, and sites failing to provide a fair balance of information
regarding the drugs' risks and benefits.96 Finally, the FDA plans to
focus its enforcement activities on the areas of unapproved new
drugs, health fraud, and prescription drugs sold without a valid
prescription.97 Of particular concern to the FDA is the sale of illegal
and non-FDA approved products. 98
89. See NABP Standards for Online Rx Expected, CHAIN DRUG REV., Apr. 26, 1999, at
RX29, available at LEXIS, News Library, CHNDRG File; see also Ukens, supra note 88, at 17.
90. See Ukens, supra note 88, at 17.
91. A search engine is an Internet tool that looks for Web sites containing words or phrases
specified by the computer user. See Mark Sableman, Link Law: The Emerging Law of Internet
Hyperlinks, 4 COMM. L. & POL'Y 557, 576 (1999).
92. See Conlan, supra note 8, at 71.
93. See Woodcock statement, supra note 19. When the FDA sends a warning letter to a
foreign pharmacy, the FDA also sends a copy to the government of the country in which the
pharmacy is located. Id.
94. See also Stephen Barlas, FDA Threatens to Turn Up Heat on Internet Pharmacies, 21
DRUG STORE NEWS, Aug. 30, 1999, at CP3.
95. See id. In one instance, a foreign site was selling an abortion kit that contained several
dangerous drugs. The FDA contacted the foreign drug company's United States Internet
service provider that voluntarily removed the ads. Id.
96. See id.
97. See Woodcock statement, supra note 19.
98. See Internet-Based Pharmacies Raising Regulatory Questions, MED. INDUS. TODAY,
Apr. 7, 1999, available at LEXIS, News Library, MEDTDY File.
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2. The Regulatory Stance of the American Medical Association
Regarding Internet Pharmacies
The AMA is not categorically opposed to Internet pharmacies
although the AMA has voted to develop model state legislation to
limit Internet prescribing."9 The AMA believes that prior to writing a
prescription a physician must: (1) have access to the patient's medical
history; (2) discuss treatment alternatives with the patient and
determine the best course of treatment; (3) educate the patient about
the benefits and risks of the medication; (4) perform an examination
under most circumstances; and (5) where necessary, provide
additional treatment interventions and follow-up visits, especially
when the medication may have serious side effects. 1°°
The AMA recognizes that the Internet can be used for legitimate
electronic prescribing purposes. 1°1 For example, after a physician
takes an adequate history and performs a physical examination, he
might enter a prescription order into a computer and transmit the
encrypted prescription to the patient's pharmacy.102  A second
example of Internet prescribing that the AMA considers legitimate is
where the patient or the physician uses an Internet pharmacy to order
medication refills.10 3
An electronic consult between a physician and a patient that
results in a prescription order is a final example of legitimate
prescribing. °4 According to the AMA, there can be a "legitimate
clinical decision" even in a situation where the physician does not see
the patient at the time a new prescription is ordered. 105 However, the
"key here is that the physician and patient have an ongoing
relationship, the patient routinely uses this physician, and history and
physical examination are already in the medical record.' 1 06 Thus,
prescribing medications without an in-person consultation should
only occur when the patient is already under the physician's care, the
99. See Abromowitz statement, supra note 62.
100. See id. The AMA does establish standards for the practice of medicine; however, it
does not have the authority to sanction or discipline physicians. Individual state boards of
medicine regulate the practice of medicine and have disciplinary authority. See supra Part II;
see also AMA BOT REPORT, supra note 58, at 5.
101. See Abromowitz statement, supra note 62.
102. See id.; see also AMA BOT REPORT, supra note 58, at 4. This process could reduce
prescription errors caused by illegible handwriting. See Abromowitz statement, supra note 62.
103. See Abromowitz statement, supra note 62.
104. See id.
105. See id.
106. AMA BOT REPORT, supra note 58, at 4.
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physician has the patient's medical history and physical examination
information in the patient's medical record, and the patient has
recently visited that physician.
107
3. The Regulatory Stance of the National Association of Boards of
Pharmacy's Regarding Internet Pharmacies
The National Association of Boards of Pharmacy ("NABP")
assists state licensing boards in "developing, implementing, and
enforcing uniform standards to protect the Public Health."'108 The
NABP considers the use of online medical consult questionnaires
without a legitimate physician-patient relationship to be illegal."°9
The NABP further believes that no new laws are needed to regulate
online pharmacies, 110 and emphasizes the necessity of cooperation
between state pharmacy and medical boards."'
In 1999, the NABP established its Verified Internet Pharmacy
Practice Sites ("VIPPS") program. The VIPPS program and Web site
are designed to assist the public in identifying properly licensed
Internet pharmacies that have agreed to comply with federal and
state laws and regulations governing pharmacy practice." 2  The
NABP does not regulate Internet pharmacies, rather VIPPS is a
voluntary program for which Internet pharmacies may apply.1' 3 To
become certified, pharmacies "must comply with the licensing and
inspection requirements of their state and each state to which they
dispense pharmaceuticals,"'1 4 and if there is a conflict between
individual state laws, the pharmacy must agree to comply with the
more stringent law or regulation."5 Furthermore, VIPPS-certified
pharmacies must respect patient rights to privacy, authenticate and
107. See Stolberg, supra note 57, at 1.
108. See VIPPS, at <http://www.nabp.net/vipps/intro.asp> (last modified Aug. 3,1999).
109. See Stolberg, supra note 57, at 1.
110. See Richard Monks, Congress Looks into Internet Rx., CHAIN DRUG REV., Aug. 16,
1999, at 1, available at LEXIS, News Library, CHNDRG File. Many legitimate Internet
pharmacies prefer self-regulation to new legislation and urge that no new laws are needed to
combat rogue Internet pharmacies. See Conlan, supra note 8, at 71.
111. See V1PPS Most Frequently Asked Questions, at <http://www.nabp.net/vipps/faq.asp>
(last modified Aug. 3, 1999) (on file with author); see also Ukens, supra note 1, at 63.
112. See VIPPS Disclaimer, at <http://www.nabp.netlvipps/vippsDisclaimer.asp> (last modi-
fied Aug. 3, 1999); see also Cardinale, supra note 20, at 10.
113. See VIPPS Most Frequently Asked Questions, supra note 111. The fee schedule is
divided into two groups. See VIPPS Program Fee Calculations, at <www.nabp.net/vipps/app-
info/fees.asp> (last modified Aug. 3, 1999) (on file with author).
114. See VIPPS, supra note 108.
115. See VIPPS Criteria, at <http://www.nabp.net/vipps/criteria.asp> (last modified Sept. 13,
1999).
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secure prescription orders, adhere to a recognized quality assurance
policy, and provide "meaningful consultation between patients and
pharmacists. "116
In addition to its efforts with VIPPS, the NABP organized a
summit in November of 1999 comprised of several Internet
pharmacies, government officials, consumer advocates and medical
groups to discuss the future of Internet pharmacies."7 Participants
supported the formation of an industry-wide coalition (Operation
Safe Net)118 that would develop "rational legislative and enforcement
initiatives" and create both a consumer education program and a
vehicle to report violative Internet pharmacies.11 9
4. The Regulatory Stance of the Federal Trade Commission
Regarding Internet Pharmacies
The Federal Trade Commission ("FTC") takes action 12° if a Web
site advertisement makes false or misleading claims about the safety
or efficacy of the offered medication.121 The FTC can also take action
if the Internet pharmacy misrepresents its privacy practices or gives
false statements about the site's collection and use of consumer
medical information.122 The FTC believes that judgments about the
practice of medicine and what constitutes appropriate practices by an
Internet pharmacy are best left to the state licensing authorities.
123
116. See VIPPS, supra note 108. Some additional VIPPS criteria include steps to prevent an
individual from submitting the same prescription to more than one pharmacy, establishment of
a process to verify the identity of the patient, prescriber, and, if necessary, caregiver, and
compliance with standards established by the United States Pharmacopeia for the storage and
shipment of medications to patients. See VIPPS Criteria, supra note 115.
117. See Internet Pharmacies Addressed at Summit, DRUG STORE NEWS, Nov. 29, 1999, at 4,
available at Lexis, News Library, DRGSTR File.
118. See Carol Ukens, New Coalition Set to Monitor Internet Pharmacy Practices, DRUG
TOPiCS, Dec. 6, 1999, at 116, available at Lexis, News Library, DRGTP File.
119. See Internet Pharmacies Addressed at Summit, supra note 117.
120. If the FTC finds a site to be in violation of the law, the FTC can enter into a consent
order with the pharmacy in an effort to obtain voluntary compliance. By signing a consent
order, the pharmacy is not admitting that it violated the law, but it must cease performing the
practices detailed in the complaint. If a consent agreement is unobtainable, the FTC can issue
an administrative complaint, which is heard before an administrative law judge. The judge can
then issue a cease and desist order against the pharmacy. See How the FTC Brings an Action, at
<http://www.ftc.gov/ftc/action.htm> (last updated June 17, 1999).
121. See Bernstein statement, supra note 85. The FTC derives its authority from section 5 of
the Federal Trade Commission Act. Id.; see also 15 U.S.C. § 45(a) (2000).
122. See Bernstein statement, supra note 85. The FTC has "engaged in extensive
monitoring of the privacy practices of Web sites, has conducted workshops on the issue, [and]
prepared reports to Congress on the self-regulatory efforts of industry on this topic." Id.
123. See id.
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The FTC monitors the practices of Internet pharmacies, makes
referrals to state and federal authorities, and assists those authorities
in their enforcement efforts. 124 Finally, the FTC launched Operation
Cure.All, a "comprehensive consumer education and enforcement
initiative to combat health fraud on the Internet." '25 The FTC has
reached settlements against a few Internet sites for deceptive or
unsubstantiated health claims.
26
5. The Regulatory Stance of the World Health Organization
Regarding Internet Pharmacies
The World Health Organization ("WHO") 2 ' recognizes the
potential benefits and problems of Internet prescribing practices.
28
In 1997, the World Health Assembly ("WHA")129 urged the
international community to work cooperatively to control the online
promotion, advertising, and sale of unauthorized medicines that could
lead to public health risks. 130 During a meeting in May of 1998 the
WHA urged member states31 "to review existing legislation,
regulations, and guidelines to ensure that they are applicable and
adequate to cover questions of advertising, promotion, and sale of
medical products using the Internet and to develop, evaluate, and
implement strategies for monitoring, surveillance and enforce-
ment."132
124. See id. The FFC's computer equipment enables FTC staff to locate and preserve Web
sites for evidentiary purposes. Id.
125. See id.; see also Cardinale, supra note 20, at 10.
126. See Bernstein statement, supra note 85.
127. The WHO is defined as the "directing and coordinating authority on international
health work." See About WHO: Objectives and Functions, at <http://www.who.org/about-
who/en/objectiv.htm> (last visited Feb. 1, 2000). The WHO's responsibilities include: (1)
proposing international conventions and agreements on health matters; (2) developing
international standards for pharmaceutical products; and (3) assisting in the development of an
informed public opinion regarding health matters. Id.
128. See World Health Assembly, Cross-Border Advertising, Promotion and Sale of Medical
Products Using the Internet, WHA51.9, May 16, 1998, at 1, available at <http://www.who.int/wha-
1998/pdf98/ear9.pdf>.
129. The WHA is the supreme decision-making body of the WHO. See Structure of WHO,
at <http://www.who.org/aboutwho/en/structure.htm> (last visited Feb. 2, 2000).
130. See Alexandra Marks, Snake Oil for Sale on Web; Pharmaceutical "Wild West" Worries
Officials, CHI. SUN-TIMES, May 20, 1997, at 29.
131. A list of current member states can be found at WHO Member States, at <http://
www.who.org/aboutwho/en/member.htm/> (last visited Feb. 1, 2000).
132. See World Health Assembly, supra note 128, at 2. Further, the WHA appealed to
industry, health professional, and consumer organizations "to monitor and report problem cases
and aspects of cross-border advertising, promotion, and sale of medical products using the
Internet," and "to maintain legal and ethical standards in the cross-border advertising,
promotion, and sale of medical products using the Internet." Id.
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Finally, the WHA requested that the Director-General of the
WHO encourage member states to monitor and survey such cross-
border activity and report problem incidents to the WHO. 133 The
WHA also requested the Director-General to develop a guide to
educate Internet users in obtaining "reliable, independent and
compatible" medical products information.134 That request resulted in
the WHO guide "Medical products and the Internet: A guide to
finding reliable information."'35
B. Current Statutory Law, Case Law, and Pending Legislative Action
The United States legislative and judicial systems are making
serious attempts to control the problems set forth by rogue Internet
pharmacies. 36  These endeavors occur on both a state and federal
level.
1. Federal Attempts to Regulate Internet Pharmacies
In late July of 1999, the House of Representatives Commerce
Committee's Oversight and Investigations Subcommittee initiated
hearings regarding the practices of Internet pharmacies and heard
testimony regarding both the legitimate and illegitimate use of the
Internet to prescribe and sell medications. 137  The House Commerce
Committee also commissioned the General Accounting Office




135. See WHO Guide, supra note 49.
136. Other countries are also beginning to take an active role. Europe has been considering
the issue of Internet drug sales for some time now, and the European Commission ("EC")
admits that the European Union has limited power to ban these sales. See N.J. Greenaway,
Internet and European Drug Regulation, 353 LANCET 330, 330 (1999). Recently, Thailand
police and drug officials, following a tip from Internet surfers, raided a pharmacy and
confiscated a large quantity of tranquilizers and psychotropic drugs. See Net Surfers' Tip-Off
Yields Drugs Haul, NATION, Nov. 27, 1999. The drugs, which were smuggled in from
Switzerland and offered to consumers via the pharmacy's Web site, were packed for shipment to
e-commerce consumers in Europe, the United States, and Canada. Id. Finally, the New
Zealand Medical Association has condemned the practices of an Australian-based Web site that
offers RU486, also known as the "morning-after" pill, free to any person wanting to take part in
a "worldwide scientific trial." See Internet Pill a Big Hazard Say Doctors, DOMINION, Dec. 30,
1999, at 3, available at LEXIS, News Library, DOMIN File.
137. See Monks, supra note 110, at 1.
13& See Internet-Based Pharmacies Raising Regulatory Questions, supra note 98; see also
Confidentiality and the Virtual Pharmacy, supra note 69. The GAO was also asked to evaluate
the adequacy of the NABP's VIPPS program as a self-regulatory device. See Ukens, supra note
1, at 63.
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One federal attempt to regulate Internet pharmacies was
Pennsylvania Representative Ron Klink's introduction of the Internet
Pharmacy Consumer Protection Act in August of 1999.139 The Act
requires Internet pharmacies to post certain kinds of information,
such as the address for the physical location of the pharmacy
dispensing the drug and the pharmacy's licensing state or states.
14°
Critics argue that this bill simply repeats the NABP's VIPPS program
requirements, and that the proposal will not remedy the problem of
rogue pharmacies or foreign Internet pharmacies.
141
President Clinton also jumped into the battle. In December of
1999, he proposed a new initiative that would "establish new Federal
requirements for all Internet pharmacies to ensure that they comply
with state and Federal laws [and] create new civil penalties for the
illegal sale of pharmaceuticals.' 1 42 Additionally, the government
would launch a new public education campaign emphasizing the
potential dangers of purchasing prescription medications over the
Internet.143  The President designated $10 million in the Fiscal Year
2001 budget to fund these activities.1"
2. State Attempts to Regulate Internet Pharmacies
Individual states do have prosecutorial avenues; however, one
noted difficulty is that few state pharmacy regulatory statutes have
been updated to include reference to the Internet. 14  Several states
have launched formal investigations of Internet Web sites selling
139. See H.R. 2763, 106th Cong. (1999).
140. See Barlas, supra note 94, at CP3; see also 145 CONG. REC. E1754 (Aug. 5, 1999)
(statement of Rep. Waxman).
141. See Barlas, supra note 94, at CP3.
142. See White House Press Release, supra note 39. The FDA claims that the initiative will
not preempt state law and that the FDA will "continue to defer to states to regulate the practice
of medicine and pharmacy." See U.S. Food and Drug Administration, Online Pharmacies
FAQs, at <http://www.fda.gov/oc/buyonline/faqs/html> (Jan. 28, 2000). The proposal includes
civil money penalties of $500,000 per violation if a prescription drug is sold to a consumer
without a valid prescription. Id. President Clinton's proposal requires that Internet pharmacies
demonstrate their compliance with federal and state laws to the FDA in order to receive
approval to operate. Id. If the pharmacy operates without prior FDA approval the site will be
subject to sanctions. Id. Finally, under this proposal the FDA would have administrative
subpoena authority when investigating potentially illegal Internet medication sales, which is
expected to streamline the investigative process. Id. Previously, the FDA has had to rely on the
issuance of grand jury subpoenas in order to obtain records necessary for investigating suspect
Web sites. Id.
143. See Online Pharmacies FA Qs, supra note 142.
144. See id.
145. See AMA BOT REPORT, supra note 58, at 2. Illinois and Ohio have updated their
statutes. See infra notes 165-66.
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prescription drugs.146 For example, the Ohio Attorney General has
filed cease-and-desist orders against several Internet pharmacy
sites.14
7
Furthermore, in November of 1999, the Missouri Attorney
General obtained a permanent injunction against an online clinic and
other defendants who were using the Internet to sell prescription
drugs.148 Missouri alleged that the individuals, who were fined a total
of $15,000 in civil penalties, violated state law by providing pre-
scription drugs to Missouri consumers without a license and on the
basis of information provided in online consultations. 149 Missouri also
obtained an injunction against and fined a Texas based Internet
pharmacy 15° and its owner $15,000 for the same reasons.151
Kansas is also taking legal action against certain Internet
pharmacies.15 2 The Kansas Attorney General, the Kansas State Board
of Healing Arts, and the Kansas Board of Pharmacy joined together
to file consumer protection lawsuits and restraining orders against
seven companies selling prescription only drugs over the Internet to
Kansas consumers.1 53
In October of 1999, the Illinois Attorney General and the Illinois
Department of Professional Regulations filed four lawsuits against
out-of-state doctors, pharmacies, and Internet companies.154 Illinois
alleges that the doctors and pharmacies were not licensed to operate
in Illinois and that the Web sites failed to disclose that the sites were
not licensed to serve Illinois consumers.155 The Department of
146. See Casey, supra note 22.
147. See NABP Standards for Online Rx Expected, supra note 89, at RX29.
148. See Missouri Attorney General Press Release, Nixon Obtains Order to Stop Illegal
Internet Prescribing and Sale of Drugs by Second Online Clinic and Pharmacy, at
<http://www.ago.state.mo.us/112999.htm> (Nov. 29, 1999).
149. See id. The order provides for additional fines of up to $5,000 for any violation of the
injunction. Id.
150. The Pill Box, at <http://www.pillbox.com> (last visited Feb. 1, 2000); see Janet
Gemignani, Cyberpharmacies Zapped by State Regs, Bus. & HEALTH, Dec. 1, 1999, at 12,
available at LEXIS, News Library, BHLTH File.
151. See Gemignani, supra note 150, at 12.
152. See Michael F. Conlan, Show Me State Moves to Bar Lone Star Online Pharmacy,
DRUG Topics, Aug. 16,1999, at 74, available at LEXIS, News Library, DRGTP File.
153. See Fred Charatan, Kansas Sues Internet Medicine Suppliers, BRIT. MED. J., June 26,
1999, at 1720.
154. See Douglas Holt, State Sues Out-of-State Internet Drug Dispensers, CHI. TRIB., Oct. 22,
1999, at 1. State investigators established a sting operation and searched the Web for Viagra,
Celebrex, and Proscar. Id. The cases seek to prohibit the companies from shipping medications
to Illinois and include fines starting at $50,000 per transaction. Id.
155. See id.
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Professional Regulations also issued a cease-and-desist order against
the same Texas-based Internet pharmacy that Missouri sued.
56
Finally, the state of Michigan has also joined the battle against
illegal Internet prescribing practices. In December 1999, the
Michigan Attorney General filed Notices of Intended Action
("NIA") against ten Internet pharmacies. 157 Michigan alleges vio-
lation of the Michigan Consumer Protection Act because the phar-
macies sent prescription drugs to Michigan consumers without a
proper prescription or physician supervision. 15s
IV. INTERNET PHARMACIES: DEVISING AN EFFECTIVE
REGULATORY PLAN
A. Response to the Federal-State Regulation Debate
Controversy exists over whether the federal government should
implement legislation regulating Internet pharmacies, or whether the
task should be left entirely up to the individual states. Some critics of
federal involvement argue that there currently is no need for federal
regulation of Internet pharmacies because individual states are
regulating the industry159 and that federal "intrusion" could "hobble
[E-commerce's] growth and development."' 6  Furthermore, critics
fear that such involvement would lead to federal regulation of the
practice of medicine.1
6'
On the other hand, proponents of federal involvement argue that
the current state regulatory structure lacks the ability to counter
challenges posed by Internet prescribing.162 Furthermore, federal
156. See id. The Internet pharmacy was The Pill Box <http://www.thepillbox.com>.
157. See Michigan Attorney General Press Release (Dec. 15, 1999) (on file with author).
158. See id. Knowing and persistent violation of the Michigan Consumer Protection Act can
result in fines of up to $25,000 per violation. Id.
159. See Fuller, supra note 20, at 18A. One argument against federal involvement is that
"state-based regulation safely has served consumers with respect to community-pharmacy and
multistate mail-service operations." Id.; see also States Should Control Internet Drug Sales, SAN
FRANCISCO CHRON., Jan. 3, 2000, at A18 ("States should be given every opportunity to control
drug sales within their jurisdictions before the federal government steps in.").
160. See id.; see also Controversy Ensues over Online Drug Sales, SEATTLE POST-
INTELLIGENCER, Dec. 29, 1999, at C2 ("It is a mistake to rush to regulate this industry before
we understand its full potential.") (quoting a spokesman for House of Representatives
commerce Committee Chairman Tom Bliley).
161. See Postrel, supra note 39, at A18 ("The Internet partially restores patients' rights to
choose how they buy their medications and from whom. No wonder the drug censors are so
upset.").
162. See Risks Demand Greater Oversight, USA TODAY, Jan. 3, 2000, at 18A ("This is a
national problem, and it deserves a federal solution."). Some state medical boards and state
pharmacy boards express concern that their existing enforcement tools are not adequate to
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involvement could result in effective and efficient regulation. For
example, if each state individually attacks the same illegal Internet
pharmacy, eradicating that pharmacy could be a slow, painstaking
process. Whereas, if the federal government prohibited an illegal
Internet pharmacy from doing business, "that operation is out of
business." 163
There need not be a single, exclusive answer to the question of
who should regulate Internet pharmacies. In order to both protect
consumers and maintain states' autonomy in regulating pharmacy and
medicine, the best plan combines state regulation with a limited
degree of federal regulation. Cooperation among state and federal
regulators is essential in such a joint regulatory scheme. Already,
steps have been taken to foster such a relationship-the FDA has
developed formal agreements with the NABP and the Federation of
State Medical Boards that outline the respective roles of each of these
groups.164
B. Model Legislation for State Regulation of Internet Pharmacies
Following is a draft of model legislation that a state should use to
strengthen its regulatory position regarding Internet pharmacies.
Each section of the legislation is accompanied by an explanation of
the section's intent and key points.
A Model Act for the Regulation of Internet Pharmacies
(1) All persons selling or offering to sell drugs, medicines, or other
pharmaceutical services, at retail or wholesale cost in the State,
including pharmacies providing services via the Internet, must be
licensed or registered as a drug distributor with the State Board of
Pharmacy. 165
(a) The State Board of Pharmacy shall require and provide
for an annual nonresident special pharmacy registration for all
pharmacies located outside of the State that dispense medi-
cations for State residents and mail, ship, or deliver pre-
scription medications into the State.
166
police Internet prescribing and dispensing practices. See Bernstein statement, supra note 85.
163. See Henkel, supra note 31.
164. See Online Pharmacies FAQs, supra note 142.
165. Support for this requirement can be found in Retail and Wholesale Sales of Dangerous
Drugs Online. See OHIO ADMIN. CODE § 4729-9-24 (Anderson 1999).
166. Support for this requirement can be found in the Pharmacy Practice Act of 1987, 225
ILL. COMP. STAT. 85/16a (West 1999).
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Section one clearly establishes licensing and registration require-
ments for Internet pharmacies. Arguably, meeting such a require-
ment could be a major task for pharmacies servicing a large number
of states. However, current technological advances can streamline
the application process.167 For example, the NABP is initiating a
multistate, Internet-based licensure and renewal system that allows
pharmacies and pharmacists to submit their initial license application
and renewal through the Internet. 168
(2) Nonresident special pharmacy registration shall be granted by
the Board upon disclosure and certification by the pharmacy:
(a) that it is licensed in the state in which the dispensing
facility is located and from which the drugs are dispensed; 169
(b) of the location, names, and titles, and proof of licensure
where applicable, of all principal corporate officers and all
pharmacists dispensing drugs to residents of the State;170
(c) that it is in good standing and complies with all lawful
directions and requests for information from the Board of
Pharmacy of each state in which it is licensed or registered.
The pharmacy shall respond directly to all communications
from the Board concerning emergency circumstances arising
from dispensing of drugs to residents of the State;'71
(d) that it maintains its records of drugs dispensed to residents
of this State so that the records are readily retrievable from the
records of other drugs dispensed, in the event that a complaint
should arise; 17
2
(e) that it cooperates with the Board in providing information
to the board of pharmacy of the state in which it is licensed
concerning matters related to the dispensing of drugs to
residents of this State;173
(f) that during its regular hours of operation, but not less than
six days per week, for a minimum of forty hours per week, a
toll-free telephone service is provided to facilitate commu-
nication between patients in this State and a pharmacist at the
pharmacy who has access to the patients' prescription re-
cords. 174 The toll-free number must be disclosed on the label
167. See News Releases, NABP to Initiate Multi-State, Internet-Based Licensure and Renewal
System (Dec. 22, 1999) (on file with author).
168. See id.
169. See 225 ILL. COMP. STAT. 85/16a.
170. See id.
171. See id.
172. See VIRGINIA STUDY REPORT, supra note 78, at 7; see also 225 ILL. COMP. STAT.
85/16a.
173. See 225 ILL. COMP. STAT. 85/16a.
174. See id.
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affixed to each container of drugs dispensed to residents of this
State; 175 and
(g) that the site provides for the security and confidentiality
of the medical and payment information transmitted to and
from, and stored by, the pharmacy. 17
6
Section two sets forth requirements that Internet pharmacies
must meet in order to be registered and dispense pharmaceuticals to
consumers within the state. One key requirement is that the
pharmacy maintain its records in such a manner that records of drugs
sent to the state are easily retrievable from other states' records.
Such organization is necessary should a complaint arise or if the state
should choose to investigate allegations of illegal dispensing practices.
(3) All pharmacies registered or licensed with the State Board of
Pharmacy and who sell or offer to sell drugs at retail or wholesale
cost on the Internet to persons located within the State or any other
state must make such sales only in compliance with all State and
federal laws governing the legal distribution of drugs. 17 7 Failure to
comply may result in revocation of the state license or registration.
Section three emphasizes the requirement that Internet phar-
macies are subject to and must operate in compliance with all appli-
cable federal and state laws.
(4) Pharmacies registered or licensed with the State Board of
Pharmacy and who sell or offer to sell drugs at retail or wholesale
cost on the Internet to persons located within the State or any other
state are strictly prohibited from providing such drugs on the basis
of a prescription generated from the utilization of an online
questionnaire physician consultation. Furthermore, all pharmacies
included in this section are prohibited from affiliating the site with
or relating the site, in any way, to any other site, business, or
physician that provides prescriptions for medications on the basis of
an online medical consultation questionnaire.
178
Section four prohibits dispensing a prescription promulgated
from the use of an online questionnaire medical consult. This re-
striction is in accordance with the belief that a face-to-face consul-
tation (or teleconference consultation, in certain circumstances),
complete with history and physical exam, are a necessary and integral
part of the physician-patient relationship. Prescriptions should only
be dispensed when such a relationship exists.
175. See id.; see also VIRGINIA STUDY REPORT, supra note 78, at 7.
176. See OHIO ADMIN. CODE § 4729-9-24.
177. See id.
178. See Abromowitz statement, supra note 62.
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This section restricts the Internet pharmacy from associating
itself in any way with an Internet site or business that provides
prescriptions to patients on the basis of an online medical consult
questionnaire. "Associating itself" should not be interpreted only in
terms of a business relationship, as providing a hyperlink 79 to or
advertisement for such an Internet site would qualify as an asso-
ciation.
(5) Internet sites owned and/or maintained by State registered or
licensed drug distributors must clearly and prominently display the
following information on the Internet site:
(a) the name under which drug distributor is licensed or
registered to do business in State, and the full address and
telephone number of licensed or registered site;180
(b) the name of the responsible person as it appears on the
drug distributor license or registration and the telephone
number where responsible person may be contacted;181
(c) the pharmacy's toll-free telephone number and notice of
hours of operation;
(d) a list of the states in which the drug distributor may legally
sell prescription drugs at wholesale or retail,182 and a list of the
states in which the drug distributor may not legally sell
prescription drugs at wholesale or retail;
(e) the name of each pharmacist dispensing the drugs;
(f) the name, business address, phone number, and principal
officers or owners of the online business offering prescription
drugs, if different from the pharmacy or physician;
183
(g) a privacy statement that assures the validity, accuracy, and
security of electronically transmitted prescription orders.
Furthermore, the pharmacy must assure the security of
personal information stored in and transferred between
computers. This portion of the Internet site must also provide
information regarding how the personal information will be
used and ensure that such information is not used for purposes
not disclosed without the written, informed consent of the
patient or person submitting personal information;184
179. A hyperlink permits a viewer to jump from one Web page to another. Clicking on the
link activates software code written in the language of the Web, which instructs the viewer's
Web browser software to go to the linked location. See Sableman, supra note 91, at 559.
180. See OHIO ADMIN. CODE § 4729-9-24.
181. See id.
182. See Bernstein statement, supra note 85; see also OHIO ADMIN. CODE § 4729-9-24.
183. See Bernstein statement, supra note 85.
184. Support for the privacy requirements can be found in the statements of scope of
proposed rules of the Wisconsin Administrative Pharmacy Code, 503 Wis. Admin. Reg. 13
(1997); see also OHIO ADMIN. CODE § 4729-9-24.
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(h) the name, address, and contact information of the drug
law enforcement agency in each state in which the person is
authorized to do business.'85 This may include a link to the
drug law enforcement agency's Internet site and/or its e-mail
address; 186 and
(i) the last date the information displayed on the site was
updated. 187 Furthermore, this information must be updated on
a monthly basis.
Section five requires that specific information be displayed on
the Internet pharmacy Web site. Display of the pharmacy's address
will alert consumers to the fact that they are doing business with an
out-of-state company and a listing of serviceable and nonserviceable
states will easily allow the patient to determine whether they can
utilize the pharmacy for prescription purposes.
Additionally, prominent display of the privacy statement assists
the patient in determining the degree of confidentiality involved.
Pharmacies must inform the patient if the personal information
transmitted to the pharmacy will be utilized for a purpose other than
prescription fulfillment. Finally, displaying the last date the infor-
mation was updated and requiring the Internet pharmacy to update
the site on a monthly basis enables consumers to better gauge the
reliability of the posted information.
C. Combating Foreign Pharmacies
Cooperation with foreign countries and regulatory agencies is of
key importance in regulating international Internet pharmacies. 188
Recently, the FDA sent electronic warning letters to twelve foreign
Web sites selling prescription drugs to United States citizens. 189
Additional copies of the letters were sent to the Web site operators,
the United States Customs Service, and to the regulatory officials in
the countries where the operators are based.' 90 The Web site
operators were further warned that future shipments to the United
States could be detained or denied entry.
19'
185. See OHIO ADMIN. CODE § 4729-9-24.
186. See id.
187. Support for this requirement can be found in the WHO Guide, supra note 49.
188. See VIPPS Most Frequently Asked Questions, supra note 111.
189. See FDA Warns Foreign Online Drug Sites That Sales to United States May Be Illegal,
68 U.S. L. WK. 2473 (2000).
190. See id.
191. See id. The FDA also maintains a list of international Web sites that are prohibited
from shipping prescription medications to the United States. See U.S. Food and Drug
Administration Import Detention Reports for OASIS, at <http://www.fda.gov/ora/oasis/ora_
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In addition to efforts by the FDA and the FDA's regulatory
counterparts in foreign countries, industry self-policing by legitimate
Internet pharmacies and cooperation with foreign authorities will
help combat some rogue pharmacies. 192 Furthermore, encouragement
from bodies such as the WHO to its member countries will also help.
Unfortunately, the degree and methods of regulation enacted by
countries other than the United States vary greatly. This fact,
combined with the lack of FDA authority over foreign sites, makes it
especially difficult to defeat the dangers posed by international
pharmacies. Thus, the problems presented by these foreign Internet
pharmacies are likely to persist to some degree.
CONCLUSION
The Internet has revolutionized the way in which ordinary
people conduct the business of their everyday lives. People can bank,
pay bills, manage investments, as well as order books, music, and
other products and obtain information on an infinite number of topics
online. It is not surprising that such an innovation would provide a
vehicle for the lay person to educate him or herself and guide the
direction of his or her health. Nor is it surprising that the healthcare
industry would seize this opportunity to modernize a commonplace
function -prescription dispensation.
Lawful Internet pharmacies benefit a consumer's healthcare
experience in many ways. These pharmacies provide convenience
and efficiency-two advantages coveted by people living busy lives.
Consumers can take a few minutes out of their lunch break to place
an order, or they can even order the prescriptions at three o'clock in
the morning, long after many conventional pharmacies have closed.
Internet pharmacies can offer a degree of privacy not found at the
local pharmacy, and patients can obtain prescriptions and ask
questions away from the prying eyes and listening ears of neighbors,
coworkers, and other parties. Finally, Internet pharmacies assist
homebound patients and those living far from a traditional pharmacy.
However, Internet pharmacies that perform illegal dispensing
practices assert a wrath of potential dangers to a consumer's health.
Pharmacies that provide prescription medication without a valid
prescription or provide a prescription on the basis of an online
oasis-det.html> (last visited Apr. 1, 2000).
192. See Korenchuk, supra note 3, at Bll.
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questionnaire enable consumers to bypass a very important
safeguard-a face-to-face consult with a licensed physician. If a
patient is not examined by a physician and bypasses contact with a
legitimate pharmacy, he misses an important chance to be diagnosed
correctly, to uncover contraindications to prescription use and
possible drug interactions, and to learn about side effects.
Furthermore, there is no guarantee that a physician actually
reviews the online questionnaires before providing the prescription.
Even if a physician reviews the questionnaires, the patient usually
lacks any knowledge regarding the professional background of the
prescribing physician. The physician could be prescribing a
medication far beyond the realm of his specialty.
A final danger raised by unlawful Internet pharmacies is that the
pharmacy might dispense a drug manufactured by an underground
company or a company outside the United States with questionable
quality control standards. If drugs are manufactured, packaged,
transported, or stored under substandard conditions, the drugs could
contain dangerous, impure, or unknown ingredients.
It is clear that patients must be protected from such dangerous
dispensing practices. However, regulation should not only eliminate
unlawful Internet pharmacies, but should also enable the growth of a
valuable addition to both the healthcare industry and e-commerce-
the lawful Internet pharmacy. Such a goal is attainable if the federal
government and the individual states jointly regulate the industry.
The encompassing nature of federal regulations allows efficient
protection against rogue Internet pharmacies. This efficiency,
combined with the years of experience and expertise the states have
garnered in regulating the practices of pharmacy and medicine,
should pose a powerful regulatory tool.
Unfortunately, this regulatory tool does not reach beyond the
borders of the United States. Combating the unlawful activities of
foreign Internet pharmacies requires worldwide cooperation among
individual countries. Each of these individual countries mandates and
enforces its own set of medicine and pharmacy regulations.
Therefore, the goal of worldwide agreement on regulations is likely
unattainable.
Although worldwide agreement on the regulation of Internet
pharmacies is currently an impractical goal, other efforts can
significantly diminish the dangers posed by unlawful pharmacies.
Groups such as the WHO can encourage their member countries to
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strictly enforce their countries' existing regulations and advocate for
the creation of safe dispensing practices for Internet pharmacies.
Additionally, the United States, by establishing and enforcing an
effective regulatory plan, can serve as a model for other countries.
These efforts, combined with a consumer education campaign
emphasizing the potential dangers of ordering prescription medi-
cation from foreign Internet pharmacies, will help curb the delete-
rious effects of such pharmacies.

